Evidence map›Paper›PMID 42741216›Full record

SynthesisFrontiers in immunology2026

Case Report: Small bowel metastasis from esophageal squamous cell carcinoma: a case series and systematic review of clinical characteristics, tropism, and survival outcomes.

Mingyu Zhou, Yunjun Liu, Huifang Huang, Xia Chen, Qiwen Huang, Shaowei Huang, Zhichao Yan, Yuyin Chen, Junming Lin, Jiayi Huang and 3 more

Abstract readSystematic ReviewCase Reports
In one paragraph

Synthesis in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mingyu Zhou *The First School of Clinical Medicine, Guangdong Medical University, Zhanjiang, Guangdong, China.
Yunjun Liu *Department of Oncology, Maoming People's Hospital, Maoming, Guangdong, China.
Huifang Huang *Department of Oncology, Maoming People's Hospital, Maoming, Guangdong, China.
Xia Chen *Department of Oncology, Maoming People's Hospital, Maoming, Guangdong, China.
Qiwen Huang *Department of Pathology, Maoming People's Hospital, Maoming, Guangdong, China.
Shaowei HuangDepartment of Oncology, Maoming People's Hospital, Maoming, Guangdong, China.
Zhichao YanDepartment of Oncology, Maoming People's Hospital, Maoming, Guangdong, China.
Yuyin ChenDepartment of Oncology, Maoming People's Hospital, Maoming, Guangdong, China.
Junming LinDepartment of Oncology, Maoming People's Hospital, Maoming, Guangdong, China.
Jiayi HuangDepartment of Oncology, Maoming People's Hospital, Maoming, Guangdong, China.
Guankao XieDepartment of Oncology, Maoming People's Hospital, Maoming, Guangdong, China.
Yating HouDepartment of Oncology, Maoming People's Hospital, Maoming, Guangdong, China.
Yisheng HuangThe First School of Clinical Medicine, Guangdong Medical University, Zhanjiang, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Small bowel metastasis from primary esophageal carcinoma is a rare occurrence, typically indicative of advanced disease and often presenting with non-specific abdominal symptoms. Failure to consider this possibility in the differential diagnosis may lead to delayed or incorrect management. This article reports the case of a 60-year-old male with small bowel metastasis originating from esophageal squamous cell carcinoma. To better characterize this clinical entity, we also conducted a systematic review of 23 documented cases, analyzing their clinicopathological features, diagnostic approaches, treatment modalities, and prognostic outcomes. Case presentation: A 60-year-old man presented with small bowel obstruction, ultimately diagnosed as metastatic esophageal squamous cell carcinoma. Surgical resection was followed by combined immunotherapy and chemotherapy, yielding a partial response. Systematic review: We reviewed 23 published cases, highlighting a strong male predominance (82.6%), jejunal predilection, and a median survival of only 6 months post-diagnosis. Small bowel metastasis from esophageal carcinoma, though uncommon, represents a challenging clinical scenario often mimicking more common abdominal pathologies. Histopathological confirmation is essential for accurate diagnosis. Early detection and a multidisciplinary treatment approach may correlate with favorable survival trends in these advanced-stage patients. Conclusions: Small bowel metastasis should be considered in esophageal cancer patients with acute abdominal symptoms. Histopathological confirmation is crucial, and a multimodal approach may be associated with extended survival trends in selected patients.

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaIntestinal NeoplasmsIntestine, SmallCase Reports as TopicHumansMaleMiddle AgedTreatment Outcomedifferential diagnosisesophageal neoplasmsintestinal obstructionmultimodal treatmentsmall bowel metastasis

Identifiers

PMID42741216
PMCPMC13572284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.